Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Organogenesis Holdings (ORGO) Operating Margin: 2016-2024

Historic Operating Margin for Organogenesis Holdings (ORGO) over the last 9 years, with Dec 2024 value amounting to -0.27%.

  • Organogenesis Holdings' Operating Margin rose 832.00% to 13.74% in Q3 2025 from the same period last year, while for Sep 2025 it was -1.80%, marking a year-over-year increase of 101.00%. This contributed to the annual value of -0.27% for FY2024, which is 316.00% down from last year.
  • Per Organogenesis Holdings' latest filing, its Operating Margin stood at -0.27% for FY2024, which was down 109.20% from 2.89% recorded in FY2023.
  • Organogenesis Holdings' Operating Margin's 5-year high stood at 15.45% during FY2021, with a 5-year trough of -0.27% in FY2024.
  • Moreover, its 3-year median value for Operating Margin was 2.89% (2023), whereas its average is 2.52%.
  • Its Operating Margin has fluctuated over the past 5 years, first spiked by 1,933bps in 2020, then plummeted by 1,051bps in 2022.
  • Organogenesis Holdings' Operating Margin (Yearly) stood at 7.89% in 2020, then soared by 756bps to 15.45% in 2021, then plummeted by 1,051bps to 4.95% in 2022, then crashed by 205bps to 2.89% in 2023, then plummeted by 316bps to -0.27% in 2024.